(+)-Hyoscyamine
Internal ID | f13abc10-9b97-49fa-bcc5-5ca218b48669 |
Taxonomy | Alkaloids and derivatives > Tropane alkaloids |
IUPAC Name | [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate |
SMILES (Canonical) | CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3 |
SMILES (Isomeric) | CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@@H](CO)C3=CC=CC=C3 |
InChI | InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16-/m0/s1 |
InChI Key | RKUNBYITZUJHSG-QXULXFAOSA-N |
Popularity | 26,969 references in papers |
Molecular Formula | C17H23NO3 |
Molecular Weight | 289.40 g/mol |
Exact Mass | 289.16779360 g/mol |
Topological Polar Surface Area (TPSA) | 49.80 Ų |
XlogP | 1.80 |
Atomic LogP (AlogP) | 1.93 |
H-Bond Acceptor | 4 |
H-Bond Donor | 1 |
Rotatable Bonds | 4 |
(R)-atropine |
(+)-Atropine |
13269-35-7 |
Hyoscyamine, (+)- |
CHEMBL3084476 |
V3203SI72M |
R-(+)-Hyoscyamine |
UNII-V3203SI72M |
tropan-3alpha-yl (2R)-3-hydroxy-2-phenylpropanoate |
Hyoscyamine (D)- |
There are more than 10 synonyms. If you wish to see them all click here. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9762 | 97.62% |
Caco-2 | + | 0.9313 | 93.13% |
Blood Brain Barrier | + | 0.8750 | 87.50% |
Human oral bioavailability | - | 0.8571 | 85.71% |
Subcellular localzation | Lysosomes | 0.4825 | 48.25% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.9541 | 95.41% |
OATP1B3 inhibitior | + | 0.9490 | 94.90% |
MATE1 inhibitior | - | 0.9800 | 98.00% |
OCT2 inhibitior | + | 1.0000 | 100.00% |
BSEP inhibitior | - | 0.8666 | 86.66% |
P-glycoprotein inhibitior | - | 0.9389 | 93.89% |
P-glycoprotein substrate | - | 0.7721 | 77.21% |
CYP3A4 substrate | + | 0.5662 | 56.62% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | + | 0.3762 | 37.62% |
CYP3A4 inhibition | - | 0.9500 | 95.00% |
CYP2C9 inhibition | - | 0.9275 | 92.75% |
CYP2C19 inhibition | - | 0.9285 | 92.85% |
CYP2D6 inhibition | - | 0.9231 | 92.31% |
CYP1A2 inhibition | - | 0.9045 | 90.45% |
CYP2C8 inhibition | - | 0.9813 | 98.13% |
CYP inhibitory promiscuity | - | 0.9113 | 91.13% |
UGT catelyzed | + | 0.8000 | 80.00% |
Carcinogenicity (binary) | - | 0.9800 | 98.00% |
Carcinogenicity (trinary) | Non-required | 0.6945 | 69.45% |
Eye corrosion | - | 0.9897 | 98.97% |
Eye irritation | - | 0.9761 | 97.61% |
Skin irritation | - | 0.8242 | 82.42% |
Skin corrosion | - | 0.9520 | 95.20% |
Ames mutagenesis | - | 0.8400 | 84.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.6189 | 61.89% |
Micronuclear | - | 0.5700 | 57.00% |
Hepatotoxicity | - | 1.0000 | 100.00% |
skin sensitisation | - | 0.9029 | 90.29% |
Respiratory toxicity | + | 0.9556 | 95.56% |
Reproductive toxicity | + | 0.8333 | 83.33% |
Mitochondrial toxicity | + | 0.9625 | 96.25% |
Nephrotoxicity | - | 0.8448 | 84.48% |
Acute Oral Toxicity (c) | III | 0.7806 | 78.06% |
Estrogen receptor binding | - | 0.7539 | 75.39% |
Androgen receptor binding | - | 0.6929 | 69.29% |
Thyroid receptor binding | - | 0.8320 | 83.20% |
Glucocorticoid receptor binding | - | 0.8661 | 86.61% |
Aromatase binding | - | 0.7444 | 74.44% |
PPAR gamma | + | 0.5318 | 53.18% |
Honey bee toxicity | - | 0.9334 | 93.34% |
Biodegradation | - | 0.6500 | 65.00% |
Crustacea aquatic toxicity | - | 0.5555 | 55.55% |
Fish aquatic toxicity | - | 0.5515 | 55.15% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL216 | P11229 | Muscarinic acetylcholine receptor M1 |
0.44 nM 0.25 nM 0.2692 nM |
Ki Ki Ki |
via Super-PRED
via Super-PRED via Super-PRED |
CHEMBL211 | P08172 | Muscarinic acetylcholine receptor M2 |
0.8128 nM 2.818 nM 0.912 nM |
Ki Ki Ki |
via Super-PRED
via Super-PRED via Super-PRED |
CHEMBL245 | P20309 | Muscarinic acetylcholine receptor M3 |
0.5 nM 0.2692 nM 0.53 nM 3.2 nM |
Ki Ki Ki IC50 |
via Super-PRED
via Super-PRED via Super-PRED via Super-PRED |
CHEMBL1821 | P08173 | Muscarinic acetylcholine receptor M4 |
0.34 nM 0.64 nM |
Ki Ki |
via Super-PRED
via Super-PRED |
CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 |
0.14 nM 0.21 nM 0.6 nM |
Ki Ki Ki |
via Super-PRED
via Super-PRED via Super-PRED |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit |
10000 nM 10000 nM 4466.8 nM 4466.8 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.65% | 96.09% |
CHEMBL2581 | P07339 | Cathepsin D | 95.13% | 98.95% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 90.58% | 95.56% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 87.62% | 86.33% |
CHEMBL5028 | O14672 | ADAM10 | 85.25% | 97.50% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 85.24% | 91.19% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 84.57% | 97.09% |
CHEMBL1899 | P46098 | Serotonin 3a (5-HT3a) receptor | 84.38% | 100.00% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 82.45% | 90.17% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 82.31% | 99.17% |
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 81.67% | 97.25% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 80.19% | 82.69% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Atropa belladonna |
Datura metel |
Datura stramonium |
Hyoscyamus albus |
Hyoscyamus niger |
Linum usitatissimum |
Lycium barbarum |
Lycium chinense |
Scopolia carniolica |
Scopolia japonica |
PubChem | 637577 |
NPASS | NPC169485 |
ChEMBL | CHEMBL1379091 |
LOTUS | LTS0057506 |
wikiData | Q104393164 |